Rhythm Pharmaceuticals (RYTM) Selling, General & Administrative (2016 - 2026)

Rhythm Pharmaceuticals (RYTM) Selling, General & Administrative (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -10.08 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 2.17 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 555.10 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 17.02 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -355.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 101.25 Mn
10 Rhythm Pharmaceuticals 6.99 Bn 6.64 Bn 52.96 Mn 63.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 63.59 Mn
Dec 31, 2025 57.48 Mn
Sep 30, 2025 52.43 Mn
Jun 30, 2025 45.95 Mn
Mar 31, 2025 39.09 Mn
Dec 31, 2024 38.13 Mn
Sep 30, 2024 35.38 Mn
Jun 30, 2024 36.42 Mn
Mar 31, 2024 34.38 Mn
Dec 31, 2023 32.37 Mn
Sep 30, 2023 30.48 Mn
Jun 30, 2023 30.05 Mn
Mar 31, 2023 24.63 Mn
Dec 31, 2022 26.32 Mn
Sep 30, 2022 21.94 Mn
Jun 30, 2022 22.33 Mn
Mar 31, 2022 21.45 Mn
Dec 31, 2021 21.00 Mn
Sep 30, 2021 17.51 Mn
Jun 30, 2021 15.47 Mn